4.89
0.08 (1.66%)
| Previous Close | 4.81 |
| Volume | 92,860 |
| Avg. Volume (3M) | 45,214 |
| Market Cap | 62,016,060 |
| Price / Earnings (TTM) | 23.29 |
| Price / Sales | 0.350 |
| Price / Book | 1.82 |
| 52 Weeks Range | |
| Earnings Date | 4 Feb 2027 |
| TTM Dividend Yield | 3.89% |
| Profit Margin | 1.58% |
| Operating Margin (TTM) | 2.50% |
| Diluted EPS (TTM) | 0.210 |
| Quarterly Revenue Growth (YOY) | -22.00% |
| Quarterly Earnings Growth (YOY) | 109.20% |
| Total Debt/Equity (MRQ) | 28.28% |
| Current Ratio (MRQ) | 1.91 |
| Operating Cash Flow (TTM) | 13.08 M |
| Levered Free Cash Flow (TTM) | 13.40 M |
| Return on Assets (TTM) | 4.45% |
| Return on Equity (TTM) | 8.19% |
AIStockmoo Score
| Value 30% | 0.3 |
| The price implies earnings growth of 13.5% a year; the business can fund about 1.3% a year. info | |
| Cheaper than its usual valuation. info | |
| Earns well above its cost of capital. Returns on capital rising. info | |
| Low debt. Ample short-term liquidity. Positive cash flow. info | |
| From our AI Insight report's view of expected return against risk. info | NA |
| Relative Valuation info | NA |
| Holdings' Value info | NA |
| Risk Premium info | NA |
| Market Valuation info | NA |
| Timing 30% | -3.5 |
| No clear trend over the past year. Far below its 52-week high. info | |
| In a downtrend: the price is below its moving averages, and they are falling. It is close to them. Volume is heavier on up days. info | |
| From our AI technical analysis of the chart. info | NA |
| Candle Patterns info | NA |
| Sentiment 20% | -0.3 |
| No recent price targets, so based on how targets have been revised. info | |
| Recent news mixed or neutral. info | |
| Holdings' Sentiment info | NA |
| Smart Money 20% | -1.4 |
| Insiders net selling recently. info | |
| Institutions net -2.90% of shares in their latest 13F filings: 31 holders increased, 52 decreased (quarter to 30 Sep 2026). info | |
| Short interest -25.8% from 31 Aug to 30 Oct 2026, 42.1 days to cover (FINRA). info | |
| Market and sector conditions are poor. | |
| Market environment cautious. info | |
| Sector lagging the market. | |
| The pillars agree, so the score is strengthened. | |
| Not in score | |
| Earnings per share have gone up and down. info | |
| Below its medium-term trend line. info | |
| Price is low against its 52-week average. Down over 5 years. info | |
| Trend down on all three terms. Short-term momentum falling. info | |
| Price is near support. Levels trending up. info | |
| Final Score | -1.67 |
Market Trend
| Short Term | Medium Term | ||
| Industry | Packaged Foods (US) | Mixed | Bearish |
| Packaged Foods (Global) | Bearish | Bearish | |
| Stock | Lifevantage Corporation | Mixed | Mixed |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B | Score |
|---|---|---|---|---|---|
| LFVN | 62 M | 3.89% | 23.29 | 1.82 | -1.7 |
| CPB | 7 B | 5.97% | 18.15 | 1.89 | -0.2 |
| PPC | 7 B | - | 21.34 | 1.70 | 0.0 |
| CENT | 3 B | - | 16.94 | 1.70 | 0.6 |
| SENEB | 1 B | - | 10.12 | 1.52 | 0.2 |
| WEST | 723 M | - | - | - | -0.4 |
Select this tab to load the latest available analysis.
|
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands. |
|
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Investment Style | Small Value |
| % Held by Insiders | 14.30% |
| % Held by Institutions | 52.25% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Advyzon Investment Management, Llc | 30 Sep 2026 | 100,678 |
| Indivisible Partners | 30 Sep 2026 | 98,842 |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BEINDORFF MICHAEL A | - | 5.04 | -10,000 | -50,400 |
| Aggregate Net Quantity | -10,000 | |||
| Aggregate Net Value ($) | -50,400 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 5.04 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| BEINDORFF MICHAEL A | Director | 12 Nov 2026 | Sell (-) | 10,000 | 5.04 | 50,400 |
Institutions
Institutional ownership: 50.50%
| Positions | Holders | Shares |
|---|---|---|
| Increased | 31 | 734,211 |
| Decreased | 52 | 866,403 |
| New | 10 | 42,789 |
| Sold out | 18 | 287,341 |
SEC 13F filings via Nasdaq, latest filings up to 30 Sep 2026. Filings arrive up to 45 days after each quarter.
Short Interest
| Settlement | Shares | Days to cover |
|---|---|---|
| 30 Oct 2026 | 906,622 | 42.1 |
| 15 Oct 2026 | 976,051 | 28.8 |
| 30 Sep 2026 | 1,068,085 | 32.6 |
| 15 Sep 2026 | 1,137,906 | 23.6 |
| 31 Aug 2026 | 1,221,521 | 22.2 |
| 14 Aug 2026 | 1,207,968 | 21.2 |
FINRA short interest via Nasdaq, reported twice a month.
| Date | Type | Details |
|---|---|---|
| 10 Nov 2026 | Yahoo Finance |
Lifevantage Corp (LFVN) (Q1 2027) Earnings Call Highlights: Revenue Slides 22% as Strategic ...
Lifevantage Corp (LFVN) posted a $37.1 million quarterly revenue decline but preserved a debt-free balance sheet while investing in a digital overhaul and brand repositioning. |
| 09 Nov 2026 | Yahoo Finance |
LifeVantage Corporation Q1 2027 Earnings Call Summary
Moby summary of LifeVantage Corporation's Q1 2027 earnings call… |
| 09 Nov 2026 | Yahoo Finance |
LifeVantage (LFVN) Q1 2027 Earnings Call Transcript
Sales slid 22% as management overhauls strategy and shifts its fiscal calendar. |
| 09 Nov 2026 | Yahoo Finance |
What Lifevantage (LFVN) Said on Its Q1 Earnings Call
Lifevantage (NASDAQ:LFVN) reported a 22% decline in revenue for its fiscal first quarter and outlined a strategy to overhaul its brand, digital sales tools and cost structure as it works to stabilize the business. Revenue for the quarter ended September 30, 2026, fell to $37.1 million from $47.6 mi… |
| 09 Nov 2026 | Yahoo Finance |
Lifevantage (LFVN) Surpasses Q1 Earnings Estimates
Lifevantage (LFVN) delivered earnings and revenue surprises of +66.67% and -3.84%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock? |
| 09 Nov 2026 | Yahoo Finance |
Lifevantage: Fiscal Q1 Earnings Snapshot
LEHI, Utah (AP) — LEHI, Utah (AP) — Lifevantage Corp. (LFVN) on Monday reported a loss of $196,000 in its fiscal first quarter. |
| 09 Nov 2026 | Yahoo Finance |
LifeVantage Declares Quarterly Dividend
SALT LAKE CITY, Nov. 09, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash… |
| 09 Nov 2026 | Yahoo Finance |
LifeVantage Announces Financial Results for the First Quarter Fiscal 2027
SALT LAKE CITY, Nov. 09, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its quarter ended September 30, 2026. First Quarter… |
| 29 Oct 2026 | Yahoo Finance |
Pro-Dex, Inc. (PDEX) Q1 Earnings and Revenues Surpass Estimates
ProDex (PDEX) delivered earnings and revenue surprises of +37.31% and +0.78%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock? |
| 29 Oct 2026 | Yahoo Finance |
New LifeVantage Research Explores How Protandim® Nrf2 Supports Cellular Defense Against Five Modern Environmental Toxins*
SALT LAKE CITY, Oct. 29, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN) continues to lead the next generation of healthy aging with its latest in vitro research study examining how five modern environmental toxins—pollution, microplastics, ultra-processed foods, hormone… |
| 26 Oct 2026 | Yahoo Finance |
LifeVantage to Announce First Quarter Fiscal Year 2027 Results on November 9, 2026
SALT LAKE CITY, Oct. 26, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its first quarter ended… |
| 19 Oct 2026 | Yahoo Finance |
New Strong Sell Stocks for October 19th
CWH, LFVN and CGAU have been added to the Zacks Rank #5 (Strong Sell) List on October 19, 2026… |
| 12 Oct 2026 | Yahoo Finance |
LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SALT LAKE CITY, Oct. 12, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”) today announced that its Board of Directors granted inducement awards to Terrence Moorehead, the Company’s President and Chief Executive Officer, under the Company’s 2026 New… |
| 24 Sep 2026 | Yahoo Finance |
LifeVantage Unveils Turnaround Plan to Rebuild Brand, Margins and Growth
Lifevantage (NASDAQ:LFVN) executives outlined a turnaround plan centered on strengthening the company’s brand, improving consumer relevance and increasing operating efficiency during a Water Tower Research conference discussion. President and CEO Terrence Moorehead, who recently joined the company,… |
| 18 Sep 2026 | Yahoo Finance |
LifeVantage to Participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026
SALT LAKE CITY, Sept. 18, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Terrence Moorehead, Chief Executive Officer, and Carl Aure, Chief… |
| 31 Aug 2026 | Yahoo Finance |
LifeVantage (LFVN) Q4 2026 Earnings Call Transcript
Revenue fell 23% as macroeconomic pressures weighed on orders and average order sizes. |
| 28 Aug 2026 | Yahoo Finance |
LifeVantage Corporation Q4 2026 Earnings Call Summary
Moby summary of LifeVantage Corporation's Q4 2026 earnings call… |
| 28 Aug 2026 | Yahoo Finance |
Lifevantage Corp (LFVN) (Q4 2026) Earnings Call Highlights: Revenue Declines 23% Amid Strategic ...
New CEO outlines turnaround plan as subscription base remains resilient despite macroeconomic headwinds… |
| Show more | ||
| TTM Dividend Yield | 3.89% |
| 4Y Average Dividend Yield | 3.77% |
| Payout Ratio | 90.48% |
| Expected Next Dividend Payment | Mar 2027 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 01 Dec 2026 | 05 Nov 2026 | 15 Dec 2026 | 0.05 Cash |
| 01 Sep 2026 | 20 Aug 2026 | 15 Sep 2026 | 0.05 Cash |
| 01 Jun 2026 | 27 Apr 2026 | 15 Jun 2026 | 0.05 Cash |
| 02 Mar 2026 | 29 Jan 2026 | 16 Mar 2026 | 0.045 Cash |
| 01 Dec 2025 | 31 Oct 2025 | 15 Dec 2025 | 0.045 Cash |
| 08 Sep 2025 | 26 Aug 2025 | 16 Sep 2025 | 0.045 Cash |
| 30 May 2025 | 29 Apr 2025 | 13 Jun 2025 | 0.045 Cash |
| 03 Mar 2025 | 03 Feb 2025 | 17 Mar 2025 | 0.04 Cash |
| 02 Dec 2024 | 25 Oct 2024 | 16 Dec 2024 | 0.04 Cash |
| 09 Sep 2024 | 26 Aug 2024 | 17 Sep 2024 | 0.04 Cash |
| 31 May 2024 | 22 Apr 2024 | 14 Jun 2024 | 0.04 Cash |
| 29 Feb 2024 | 25 Jan 2024 | 15 Mar 2024 | 0.035 Cash |
| 30 Nov 2023 | 06 Nov 2023 | 15 Dec 2023 | 0.035 Cash |
| 07 Sep 2023 | 23 Aug 2023 | 22 Sep 2023 | 0.435 Cash |
| 31 May 2023 | 27 Apr 2023 | 15 Jun 2023 | 0.035 Cash |
| 28 Feb 2023 | 26 Jan 2023 | 15 Mar 2023 | 0.03 Cash |
| 30 Nov 2022 | 28 Oct 2022 | 15 Dec 2022 | 0.03 Cash |
| 01 Sep 2022 | 18 Aug 2022 | 15 Sep 2022 | 0.03 Cash |
| 16 May 2022 | 28 Apr 2022 | 31 May 2022 | 0.03 Cash |
| Show more | |||
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2026 | 0.195 | 4 | 3.99 |
| 2025 | 0.175 | 4 | 2.84 |
| 2024 | 0.155 | 4 | 0.88 |
| 2023 | 0.535 | 4 | 8.92 |
| 2022 | 0.090 | 3 | 2.42 |
Technical Setup Medium
AI Technical Analysis
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |